No Data
China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Profits Appear To Have Quality Issues
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
CR Sanjiu Logs 18% Boost in 2024 Profit
China Resources 39:2024 Annual Report Summary
China Resources 39:2024 Annual Report
Gelonghui Announcement Highlights | China Resources Sanjiu Medical & Pharmaceutical: Net income is expected to increase by 18.05% year-on-year in 2024, proposed a 10-for-3 stock split with a distribution of 3.2 yuan; Weichai Heavy Machinery: The company's
【Hot Topic】 Henggong Precision (301261.SZ): The revenue from the related business in the fields of robot reducers and humanoid robots is relatively low. Guangxi Radio and Television Information Network Corporation (600936.SH): The Technology subsidiary "Guangdian Cloud" has integrated multiple large models including DeepSeek and QWen (Qianwen), currently this deployment is mainly applied in intelligent customer service scenarios. Garden Share Co., Ltd. (605303.SH): Cloud Needle Technology is currently in the early stage of technology achievement transformation, with a small business scale and still in a loss state. Weichai Heavy Machinery (000880.SZ): The company's Generator product can be used in Datacenters.
China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Investors Will Be Pleased With Their Strong 123% Return Over the Last Three Years
